Nuvalent, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCambridge, MA
US patents6
SAM.gov UEIDA6FDE27JX11
CAGE code212W7
Incorporated inDE
LEI529900RZ62O2T6LNQS60
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
6 US patents granted 2023–2025, 6 of them in the five years to SEP 2025.
Organic fine chemistry 5Pharmaceuticals 1
- Heteroaromatic macrocyclic ether chemotherapeutic agentsUS 12,275,742 · granted APR 15, 2025
- Heteroaromatic macrocyclic ether chemotherapeutic agentsUS 12,054,498 · granted AUG 6, 2024
- Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compoundsUS 12,043,626 · granted JUL 23, 2024
- Amino-substituted heteroaryls for treating cancers with EGFR mutationsUS 12,037,346 · granted JUL 16, 2024
- Heteroaromatic macrocyclic ether chemotherapeutic agentsUS 11,667,649 · granted JUN 6, 2023
Newest 5 shown · Granted to Nuvalent, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Nuvalent, INC. | Cambridge | MA | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.